Position in VTRS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$39,282,278
+$9,027,414 QoQ
Shares Held
2,907,645
+19.7% QoQ
Ownership
0.250%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 98.5932601813495.ToString("F0")%
Shared 0.07524990155263109.ToString("F0")%
None 1.3314899170978576.ToString("F0")%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026ROYAL BANK OF CANADA holds $672,203,105 across 64 Drug Manufacturers - Specialty & Generic names. VTRS ranks #5 (5.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
1,974,284 | $233,380,104 | |
| 2 | RDY |
Dr Reddys Laboratories Ltd
|
9,984,082 | $138,279,533 | |
| 3 | BHC |
Bausch Health Companies Inc.
|
11,363,498 | $61,362,887 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
332,300 | $43,777,199 | |
| 5 | VTRS |
Viatris Inc
This page
|
2,907,645 | $39,282,278 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
|
59,152 | $35,075,949 | |
| 7 | HLN |
Haleon plc
|
3,063,916 | $30,669,795 | |
| 8 | TEVA |
Teva Pharmaceutical Industries Ltd
|
963,824 | $29,030,375 |
All Filings in VTRS
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $39,282,278 | 2,907,645 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $30,254,864 | 2,430,110 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $31,095,827 | 3,140,993 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $29,679,843 | 3,323,611 | Shares | Defined | 2025-11-21 | |
| 2025-03-31 | $30,600,125 | 3,513,218 | Shares | Defined | 2025-11-21 | |
| 2024-12-31 | $40,916,734 | 3,286,485 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $29,779,379 | 2,564,977 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $24,261,652 | 2,282,376 | Shares | Defined | 2024-11-06 | |
| 2024-03-31 | $24,530,068 | 2,054,445 | Shares | Defined | 2024-11-05 | |
| 2023-12-31 | $26,093,624 | 2,409,384 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $28,777,972 | 2,918,659 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $30,585,911 | 3,064,721 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $24,900,027 | 2,588,361 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $29,260,332 | 2,628,961 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $30,694,531 | 3,602,645 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $36,507,220 | 3,486,841 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $27,817,554 | 2,556,761 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $45,653,959 | 3,374,277 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $44,898,231 | 3,313,523 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $56,061,164 | 3,923,105 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $44,400,452 | 3,178,272 | Shares | Defined | 2021-07-20 | |
| 2020-12-31 | $56,948,545 | 3,038,877 | Shares | Defined | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||